Study Stopped
Study was closed due to logistical issues.
Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The results of this study may or may not establish useful baseline data, which will help us understand how bone marrow derived adult liver stem cells behave in normal healthy adults/volunteers (the control group), and in patients undergoing liver surgery. The bone marrow is located within your bones and is the organ which is responsible to produce blood cells and stem cells. Bone marrow derived adult liver stem cells are normal cells in your bone marrow. These liver stem cells have the capacity to regenerate or in other words to rebuild the liver after liver surgery, a process called liver regeneration. These cells are very important for the liver to regrow its tissue after liver surgery. These cells are thought to be activated in times of need by the liver. Situations like liver surgery are one of these occasions when the liver will need the "extra help" from these stem cells. The results of this study will establish the baseline data necessary for the understanding of how to harness the ability of these stem cells in times of liver surgery. Improvements in the ability of the liver to regrow after surgery is thought to decrease complications related to liver surgery. Harnessing this unique ability of stem cells may be utilized in the future to enhance the regrowing process of liver tissue after liver surgery, called liver regeneration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2006
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 17, 2008
CompletedFirst Posted
Study publicly available on registry
January 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedMarch 19, 2009
March 1, 2009
3 years
January 17, 2008
March 18, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine qualitatively and quantitatively whether bone marrow derived liver associated stem cells are mobilized from the bone marrow in patients undergoing major liver resections (3 or more liver segments).
conclusion of study
Secondary Outcomes (1)
To determine whether a difference exist in the baseline levels of bone marrow derived liver associated stem cells between normal healthy subjects/ volunteers and cancer patients prior to liver surgery.
conclusion of study
Study Arms (2)
1
normal healthy volunteers
2
Patients undergoing major liver resections
Interventions
Baseline levels of bone marrow derived liver stem cells from normal healthy volunteers, which will be drawn once Two 5ml blue tubes).
Eligibility Criteria
MSKCC clinics Normal healthy volunteers
You may qualify if:
- Adults (≥ or equal to 18 years old).
- Patients scheduled for resection of 3 or more liver segments for any indication, with or without other planned procedures.
- Normal healthy volunteers (control).
You may not qualify if:
- Chemotherapy or GCSF treatment in the preceding 4 weeks.
- CHILD'S classification B or above.
- Presence of active infection.
- History of lymphoma or leukemia.
- Normal healthy volunteers who underwent chemotherapy treatment at any stage of their life will be excluded.
- Normal healthy volunteers who are under any active treatment for any active illness will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
Biospecimen
Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald DeMatteo, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 17, 2008
First Posted
January 31, 2008
Study Start
March 1, 2006
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
March 19, 2009
Record last verified: 2009-03